[CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma]

Rinsho Ketsueki. 1996 Aug;37(8):676-81.
[Article in Japanese]

Abstract

A case of acute undifferentiated leukemia (AUL), accompanied by subcutaneous tumor and thymoma is reported. The analysis of immunophenotype showed that the leukemic blasts were positive for CD7, HLA-DR, CD38 and CD34 in 17.5% but negative results were obtained for other lymphoid and myeloid antigens. The leukemic blasts had a rearranged immunoglobulin heavy chain (IgH) gene and T cell receptor delta (TCR-delta) chain gene chromosomal abnormality, 47, XY, +8, t(13; 17) (q12; q21), -17, +M was observed. In general, the CR rate is low and prognosis is poor in patients with AUL. In our case, CR was not achieved by the therapy with JALSG-ALL87 protocol, but was achieved by subsequent treatment with high dose ara-C therapy and combination chemotherapy including intermediate-dose ara-C, mitoxantrone, etoposide and prednisolone.

MeSH terms

  • ADP-ribosyl Cyclase
  • ADP-ribosyl Cyclase 1
  • Acute Disease
  • Antigens, CD*
  • Antigens, CD7 / analysis*
  • Antigens, Differentiation / analysis*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chromosome Aberrations
  • Chromosome Disorders
  • Cytarabine / administration & dosage
  • Etoposide / administration & dosage
  • Gene Rearrangement
  • HLA-DR Antigens / analysis*
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Immunophenotyping
  • Leukemia / complications
  • Leukemia / drug therapy
  • Leukemia / immunology*
  • Membrane Glycoproteins
  • Mitoxantrone / administration & dosage
  • N-Glycosyl Hydrolases / analysis*
  • Prednisolone / administration & dosage
  • Receptors, Antigen, T-Cell, gamma-delta / genetics
  • Remission Induction
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / immunology*
  • Thymoma / complications
  • Thymoma / drug therapy
  • Thymoma / immunology*
  • Thymus Neoplasms / complications
  • Thymus Neoplasms / drug therapy
  • Thymus Neoplasms / immunology*

Substances

  • Antigens, CD
  • Antigens, CD7
  • Antigens, Differentiation
  • HLA-DR Antigens
  • Immunoglobulin Heavy Chains
  • Membrane Glycoproteins
  • Receptors, Antigen, T-Cell, gamma-delta
  • Cytarabine
  • Etoposide
  • Prednisolone
  • Mitoxantrone
  • N-Glycosyl Hydrolases
  • ADP-ribosyl Cyclase
  • CD38 protein, human
  • ADP-ribosyl Cyclase 1